This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

StemCells, Inc. Adds Serum-Free And Animal Component-Free Cell Culture Supplements To Its SC Proven(R) Product Portfolio

Stocks in this article: STEM

PALO ALTO, Calif., March 29, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today the launch of three new cell culture supplements for the derivation, culture and differentiation of human and mouse embryonic stem (ES) cells, induced pluripotent stem (iPS) cells, and tissue-derived neural stem (NS) cells. 1-13 The research community demands reliable and cost-effective options for the reagents they routinely use to capture, define and instruct stem cell behavior. These new supplements satisfy this demand by providing researchers with additional choices to use either a defined, serum-free, or a defined, serum-free and animal component-free (AF) version of culture supplements that are considered to be fundamental reagents for stem cell research.

"We are pleased to continue growing and diversifying our SC Proven ® reagents business to meet the needs of the burgeoning stem cell research market," said Stewart Craig, Ph.D., Senior Vice President, Development and Operations at StemCells, Inc.  "In 2010, SC Proven product sales revenue grew by approximately 30%, and we are continuing to experience double digit growth this year. 

 "Our expanding line of SC Proven cell culture supplements provides researchers with well-defined reagents that are free of the serum and animal protein-derived contaminants that can cause variability of performance and impair analyses, particularly in the context of stem cell-based drug screens," continued Dr. Craig. "Furthermore, the use of animal component-free formulations is an important consideration for researchers considering bench-to-bedside applications in which human stem cell lines may be derived, expanded and banked for potential future translation into clinical trials."

NDiff ® N2-AF is a proprietary, defined, serum-free and animal component-free version of the Company's NDiff N2 product, a proprietary, defined, serum-free cell culture supplement based on the original Bottenstein formulation. 1

NDiff N27 is a proprietary, defined, serum-free cell culture supplement based on the original Brewer formulation. 2

NDiff N27-AF is a proprietary, defined, serum-free and animal component-free version of NDiff N27.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,907.78 +102.98 0.58%
S&P 500 2,073.15 +2.50 0.12%
NASDAQ 4,777.3040 +11.9240 0.25%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs